aod9604 clinical trial obesity results AOD-9604 (5mg) – Nordsci AOD 9604 Peptide Guide: Dosing,

Benefits outlined are based on third-party studies

Previous work has reported relatively increased Firmicutes and Proteobacteria and decreased Bacteroidetes in mice on an HFD, regardless of concomitant obesity (weight gain was minimized using a RELM knockout mouse 78 ) 78,79

Nonetheless, this work has identified novel findings that support future studies to determine whether microbiome changes are contingent upon the combination of both NNMTi and LD switch and mediated through direct NNMTi-driven mechanisms or through indirect mechanisms such as weight or fat loss 8,13

[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Zha, S., Li, Z., Cao, Q., Wang, F